Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0G5BL
|
|||
Drug Name |
RG7880
|
|||
Indication | Diabetic foot ulcer [ICD-11: BD54; ICD-9: 707] | Phase 2 | [1] | |
Ulcerative colitis [ICD-11: DD71; ICD-9: 556] | Phase 1 | [2] | ||
Company |
Genentech South San Francisco, CA
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Interleukin-22 (IL22) | Target Info | Modulator | [3] |
NetPath Pathway | IL9 Signaling Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of Roche. | |||
REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.